ALGIAX

Algiax Pharmaceuticals is a young, innovative research company in the field of neurological diseases with a special focus on neuropathic pain.

Press releases

Press
14. May 2012
High-Tech Gründerfonds, Private Investors and KfW invest €4.3 million in Algiax Pharmaceuticals GmbH
Advanced Therapy for Neuropathic Pain Algiax Pharmaceuticals GmbH, headquartered in Erkrath, is a biotechnology research company which was founded in July 2011. It is dedicated to drug development addressing central nervous system (CNS) illnesses and dysfunctions, with a focus on neuropathic pain. A consortium of private investors, as well as KfW and High-Tech Gründerfonds, are investing approx. €4.3 million in Algiax in a first closing. Pain is the primary reason for a visit to a docto
 

Info & Contact

Ingo Lehrke
Web:
www.algiax.com

Address

Max-Planck-Straße 15a
40699 Erkrath

In portfolio

13. Jan 2012

Sector

HTGF Manager

 
Dr. Frank Hensel, Principal / Authorized signatory